VYNE THERAPEUTICS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by VYNE THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14CITADEL ADVISORS LLCVYNE Therapeutics Inc.-8.5%EDGAR
SC 13G/A2024-02-02Soleus Capital Master Fund, L.P.VYNE Therapeutics Inc.703,8685.0%EDGAR
SC 13D2023-11-13AI Biotechnology LLCVYNE Therapeutics Inc.3,201,980-EDGAR
SC 13G2023-11-13Cormorant Asset Management, LPVYNE Therapeutics Inc.1,394,336-EDGAR
SC 13G2023-11-13CITADEL ADVISORS LLCVYNE Therapeutics Inc.-8.5%EDGAR
SC 13G2023-11-13EVENTIDE ASSET MANAGEMENT, LLCVYNE Therapeutics Inc.1,394,33610.0%EDGAR
SC 13G2023-11-02Soleus Capital Master Fund, L.P.VYNE Therapeutics Inc.890,8686.4%EDGAR
SC 13G/A2022-02-15PERCEPTIVE ADVISORS LLCVYNE Therapeutics Inc.2,425,6044.5%EDGAR
SC 13G/A2021-08-25PERCEPTIVE ADVISORS LLCVYNE Therapeutics Inc.4,987,8879.6%EDGAR
SC 13G/A2021-07-12BlackRock Inc.VYNE Therapeutics Inc.1,037,6772.0%EDGAR
SC 13G/A2021-02-16Point72 Asset Management, L.P.VYNE Therapeutics Inc.00.0%EDGAR
SC 13G/A2021-02-16FIRST MANHATTAN COVYNE Therapeutics Inc.21,3190.0%EDGAR
SC 13G/A2021-02-16GREAT POINT PARTNERS LLCVYNE Therapeutics Inc.00.0%EDGAR
SC 13G/A2021-02-16PERCEPTIVE ADVISORS LLCVYNE Therapeutics Inc.27,095,81914.3%EDGAR
SC 13G/A2021-02-11JANUS HENDERSON GROUP PLCVYNE Therapeutics Inc.00.0%EDGAR
SC 13G2021-02-02BlackRock Inc.VYNE Therapeutics Inc.11,988,7677.1%EDGAR
SC 13G/A2020-06-11Vivo Capital VIII, LLCMenlo Therapeutics Inc.3,643,8242.2%EDGAR
SC 13G2020-06-11PERCEPTIVE ADVISORS LLCMenlo Therapeutics Inc.22,876,41014.0%EDGAR
SC 13D/A2020-04-16venBio Global Strategic Fund II L.P.Menlo Therapeutics Inc.00.0%EDGAR
SC 13G/A2020-02-14GREAT POINT PARTNERS LLCMenlo Therapeutics Inc.1,652,0136.8%EDGAR
External links